The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Emerging functions of serum amyloid A in inflammation
Open accessAbstract
SAA is a major acute-phase protein produced in large quantity during APR. The rise of SAA concentration in blood circulation during APR has been a clinical marker for active inflammation. In the past decade, research has been conducted to determine whether SAA plays an active role during inflammation and if so, how it influences the course of inflammation. These efforts have led to the discovery of cytokine-like activities of rhSAA, which is commercially available and widely used in most of the published studies. SAA activates multiple receptors, including the FPR2, the TLRs TLR2 and TLR4, the scavenger receptor SR-BI, and the ATP receptor P2X7. More recent studies have shown that SAA not only activates transcription factors, such as NF-κB, but also plays a role in epigenetic regulation through a MyD88-IRF4-Jmjd3 pathway. It is postulated that the activation of these pathways leads to induced expression of proinflammatory factors and a subset of proteins expressed by the M2 macrophages. These functional properties set SAA apart from well-characterized inflammatory factors, such as LPS and TNF-α, suggesting that it may play a homeostatic role during the course of inflammation. Ongoing and future studies are directed to addressing unresolved issues, including the difference between rSAA and native SAA isoforms and the exact functions of SAA in physiologic and pathologic settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 2×
“Central to these changes is the hepatic production of acute-phase proteins, including SAA, C-reactive protein, and complement proteins [2].”
BackgroundBaumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1920 · Cited by 1,156
Serum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C. M., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,106
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
Self-citationEndogenous ligands of Toll-like receptors
Tsan, M.-F., & Gao, B. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304127 · Cited by 685
The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase
Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake, K., Shibuya, M., Akira, S., Aburatani, H., & Maru, Y. (2008) · Nature Cell Biology · doi:10.1038/ncb1794 · Cited by 642
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Modulation of atherosclerosis in mice by Toll-like receptor 2
Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549
Friendly and dangerous signals: is the tissue in control?
Matzinger, P. (2007) · Nature Immunology · doi:10.1038/ni0107-11 · Cited by 532
Badolato, R., Wang, J. M., Murphy, W. J., Lloyd, A. R., Michiel, D. F., Bausserman, L. L., Kelvin, D. J., & Oppenheim, J. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.203 · Cited by 500
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Amyloid protein SAA is associated with high density lipoprotein from human serum.
Benditt, E. P., & Eriksen, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.4025 · Cited by 430
Su, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 429
Regulation of serum amyloid A protein expression during the acute-phase response
JENSEN, L. E., & WHITEHEAD, A. S. (1998) · Biochemical Journal · doi:10.1042/bj3340489 · Cited by 411
Serum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329
Self-citationDe Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304
Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M. H., Öörni, K., Wolff, H., Kovanen, P. T., Matikainen, S., & Eklund, K. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002843 · Cited by 298
Meek, R. L., Urieli-Shoval, S., & Benditt, E. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3186 · Cited by 298
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284 · cited 6×
“SAA stimulation of these 2 receptors results in MyD88-dependent signaling, including phosphorylation of ERK and p38 MAPK, as well as transcriptional activation that leads to increased expression of IL-1b, TNF-a, IL-12p40, IL-1rn, and IL-10 [34] and elevated production of NO [43].”
BackgroundInfluentialSelf-citationSerum amyloid A is an innate immune opsonin for Gram-negative bacteria
Shah, C., Hari-Dass, R., & Raynes, J. G. (2006) · Blood · doi:10.1182/blood-2005-11-011932 · Cited by 245
Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice
Ather, J. L., Ckless, K., Martin, R., Foley, K. L., Suratt, B. T., Boyson, J. E., Fitzgerald, K. A., Flavell, R. A., Eisenbarth, S. C., & Poynter, M. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100500 · Cited by 239
Furlaneto, C. J., & Campa, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2143 · Cited by 223
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M., Curtiss, L. K., & de Beer, F. C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39863-1 · Cited by 197
Amyloid A gene family expression in different mouse tissues.
Meek, R. L., & Benditt, E. P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.2006 · Cited by 193
Is serum amyloid A an endogenous TLR4 agonist?
Sandri, S., Rodriguez, D., Gomes, E., Monteiro, H. P., Russo, M., & Campa, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407203 · Cited by 188
Structure of the murine serum amyloid A gene family. Gene conversion.
Lowell, C. A., Potter, D. A., Stearman, R. S., & Morrow, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83932-7 · Cited by 188
Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T., Csako, G., Thomas, F., Eggerman, T. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405009200 · Cited by 184
Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis
Lu, J., Yu, Y., Zhu, I., Cheng, Y., & Sun, P. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322357111 · Cited by 177
Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages.
Meek, R. L., Eriksen, N., & Benditt, E. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7949 · Cited by 173
Cai, L., de Beer, M. C., de Beer, F. C., & van der Westhuyzen, D. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411555200 · Cited by 173
Human Serum Amyloid A has Cytokine‐Like Properties
Patel, Fellowes, Coade, & Woo (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00394.x · Cited by 172
Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2
He, R. L., Zhou, J., Hanson, C. Z., Chen, J., Cheng, N., & Ye, R. D. (2009) · Blood · doi:10.1182/blood-2008-03-139923 · Cited by 169
Self-citationVallon, R., Freuler, F., Desta-Tsedu, N., Robeva, A., Dawson, J., Wenner, P., Engelhardt, P., Boes, L., Schnyder, J., Tschopp, C., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2801 · Cited by 164
Evolution of the Serum Amyloid A (SAA) Protein Superfamily
Uhlar, C., Burgess, C. J., Sharp, P. M., & Whitehead, A. S. (1994) · Genomics · doi:10.1006/geno.1994.1052 · Cited by 162
O’Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O., & Bresnihan, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20301 · Cited by 162
Hansen, M. T., Forst, B., Cremers, N., Quagliata, L., Ambartsumian, N., Grum-Schwensen, B., Klingelhöfer, J., Abdul-Al, A., Herrmann, P., Osterland, M., et al. (2014) · Oncogene · doi:10.1038/onc.2013.568 · Cited by 159
Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection
Derebe, M. G., Zlatkov, C. M., Gattu, S., Ruhn, K. A., Vaishnava, S., Diehl, G. E., MacMillan, J. B., Williams, N. S., & Hooper, L. V. (2014) · eLife · doi:10.7554/elife.03206 · Cited by 155
Kebir, D. E., József, L., Khreiss, T., Pan, W., Petasis, N. A., Serhan, C. N., & Filep, J. G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.616 · Cited by 147
Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue
O’Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O., & Bresnihan, B. (2000) · Arthritis Research & Therapy · doi:10.1186/ar78 · Cited by 141
Dong, Z., Wu, T., Qin, W., An, C., Wang, Z., Zhang, M., Zhang, Y., Zhang, C., & An, F. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00186 · Cited by 139
Serum Amyloid A Induces Monocyte Tissue Factor
Cai, H., Song, C., Endoh, I., Goyette, J., Jessup, W., Freedman, B., McNeil, H. P., & Geczy, C. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1852 · Cited by 123
Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23
He, R., Shepard, L. W., Chen, J., Pan, Z. K., & Ye, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4072 · Cited by 100
Self-citationSun, L., Zhou, H., Zhu, Z., Qian, Y., Wang, L., Liang, Q., & Ye, R. D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402164 · Cited by 100
Self-citationSodin-Semrl, S., Spagnolo, A., Mikus, R., Barbaro, B., Varga, J., & Fiore, S. (2004) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200401700206 · Cited by 98
A brief elevation of serum amyloid A is sufficient to increase atherosclerosis
Thompson, J. C., Jayne, C., Thompson, J., Wilson, P. G., Yoder, M. H., Webb, N. R., & Tannock, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m054015 · Cited by 95
Qian, Y., Sun, L., Zhu, Z., Wang, L., Li, S., & Ye, R. D. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.025 · Cited by 92
Self-citationChristenson, K., Björkman, L. I., Tängemo, C., & Bylund, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507276 · Cited by 88
Serum amyloid A3 does not contribute to circulating SAA levels
Chiba, T., Han, C. Y., Vaisar, T., Shimokado, K., Kargi, A. Y., Chen, M., Wang, S., McDonald, T. O., O’Brien, K. D., Heinecke, J. W., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900089-jlr200 · Cited by 84
Wilson, P. G., Thompson, J. C., Webb, N. R., de Beer, F. C., King, V. L., & Tannock, L. R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080201 · Cited by 78
den Hartigh, L. J., Wang, S., Goodspeed, L., Ding, Y., Averill, M. M., Subramanian, S., Wietecha, T., O’Brien, K. D., & Chait, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108564 · Cited by 78
O’Reilly, S., Cant, R., Ciechomska, M., Finnigan, J., Oakley, F., Hambleton, S., & van Laar, J. M. (2014) · Immunology · doi:10.1111/imm.12260 · Cited by 76
Serum Amyloid A3 Binds MD-2 To Activate p38 and NF-κB Pathways in a MyD88-Dependent Manner
Deguchi, A., Tomita, T., Omori, T., Komatsu, A., Ohto, U., Takahashi, S., Tanimura, N., Akashi‐Takamura, S., Miyake, K., & Maru, Y. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201996 · Cited by 73
Gouwy, M., Buck, M. D., Pörtner, N., Opdenakker, G., Proost, P., Struyf, S., & Damme, J. V. (2014) · European Journal of Immunology · doi:10.1002/eji.201444818 · Cited by 71
Anthony, D., McQualter, J. L., Bishara, M., Lim, E. X., Yatmaz, S., Seow, H. J., Hansen, M. J., Thompson, M. A., Hamilton, J. A., Irving, L. B., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-250332 · Cited by 61
Chen, M., Zhou, H., Cheng, N., Qian, F., & Ye, R. D. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.08.002 · Cited by 54
Self-citationBjörkman, L. I., Raynes, J. G., Shah, C., Karlsson, A., Dahlgren, C., & Bylund, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27440 · Cited by 54
Lee, J., Kim, E., Seo, H., Jeon, I., Chae, M., Park, Y., Song, B., Kim, Y., Kim, Y., Ko, H., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201343867 · Cited by 52
Marzi, C., Huth, C., Herder, C., Baumert, J. J., Thorand, B., Rathmann, W., Meisinger, C., Wichmann, H. ‐., Roden, M., Peters, A., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1514 · Cited by 51
SAA does not induce cytokine production in physiological conditions
Kim, M.-H., de Beer, M. C., Wroblewski, J. M., Webb, N. R., & de Beer, F. C. (2012) · Cytokine · doi:10.1016/j.cyto.2012.10.019 · Cited by 50
de Beer, M. C., Wroblewski, J. M., Noffsinger, V. P., Rateri, D. L., Howatt, D. A., Balakrishnan, A., Ji, A., Shridas, P., Thompson, J. C., van der Westhuyzen, D. R., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302247 · Cited by 50
Webb, N. R., de Beer, M. C., Wroblewski, J. M., Ji, A., Bailey, W. M., Shridas, P., Charnigo, R. J., Noffsinger, V. P., Witta, J., Howatt, D. A., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304776 · Cited by 47
Serum amyloid A induces interleukin‐33 expression through an IRF7‐dependent pathway
Sun, L., Zhu, Z., Cheng, N., Yan, Q., & Ye, R. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344310 · Cited by 41
Self-citationMarzi, C., Albrecht, E., Hysi, P. G., Lagou, V., Waldenberger, M., Tönjes, A., Prokopenko, I., Heim, K., Blackburn, H., Ried, J. S., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001213 · Cited by 29
Expression of Mouse Acute-Phase (SAA1.1) and Constitutive (SAA4) Serum Amyloid A Isotypes
Kindy, M. S., de Beer, M. C., Yu, J., & de Beer, F. C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1543 · Cited by 27
Up-Regulation of MUC2 Mucin Expression by Serum Amyloid A3 Protein in Mouse Colonic Epithelial Cells
Hiroaki, S., Ishiguro, N., & Inoshima, Y. (2014) · Journal of Veterinary Medical Science · doi:10.1292/jvms.14-0007 · Cited by 26
Ren, S., Qi, X., Jia, C., & Wang, Y. (2014) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2014.02.01 · Cited by 17
TLR2 in murine atherosclerosis
Tobias, P. S., & Curtiss, L. K. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0102-3 · Cited by 16
Olsson, M. M., Ahlin, S., Olsson, B., Svensson, P., Ståhlman, M., Borén, J., Carlsson, L. M. S., & Sjöholm, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019609 · Cited by 15
Cited by
Damage-associated molecular patterns in inflammatory diseases
Roh, J. S., & Sohn, D. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e27 · Cited by 1,261
Takata, F., Nakagawa, S., Matsumoto, J., & Dohgu, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661838 · Cited by 651
Sack, G. H. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0047-0 · Cited by 499
Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease
Lee, J.-Y., Hall, J. A., Kroehling, L., Wu, L., Najar, T., Nguyen, H. H., Lin, W.-Y., Yeung, S. T., Silva, H. M., Li, D., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.026 · Cited by 466
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Metadata
- Authors
- Ye, R. D., & Sun, L.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-30
- Volume
- 98
- Issue
- 6
- Pages
- 923-929
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2216860662
- Cited by
- 311
- References
- 70
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.